
浏览全部资源
扫码关注微信
1. 河北省人民医院检验科
2. 河北省人民医院中医科
纸质出版日期:2021,
扫 描 看 全 文
[1]崔佳,于芳,魏常梅,高伟,帖彦清,袁曙光.滋肾育胎丸对抗心磷脂抗体阳性复发性流产患者可溶性人白细胞抗原G、抗子宫内膜抗体水平的影响[J].中国医院用药评价与分析,2021,21(04):412-415+419.
CUI Jia, YU Fang, WEI Changmei, et al. Effect of Zishen Yutai Pills on the Level of Soluble Human Leukocyte Antigen G and Anti-Endometrial Antibody in Patients with Recurrent Abortion with Positive Anticardiolipin Antibody[J]. 2021,21(4):412-415.
[1]崔佳,于芳,魏常梅,高伟,帖彦清,袁曙光.滋肾育胎丸对抗心磷脂抗体阳性复发性流产患者可溶性人白细胞抗原G、抗子宫内膜抗体水平的影响[J].中国医院用药评价与分析,2021,21(04):412-415+419. DOI: 10.14009/j.issn.1672-2124.2021.04.007.
CUI Jia, YU Fang, WEI Changmei, et al. Effect of Zishen Yutai Pills on the Level of Soluble Human Leukocyte Antigen G and Anti-Endometrial Antibody in Patients with Recurrent Abortion with Positive Anticardiolipin Antibody[J]. 2021,21(4):412-415. DOI: 10.14009/j.issn.1672-2124.2021.04.007.
目的:探讨滋肾育胎丸对抗心磷脂抗体(ACA)阳性复发性流产患者可溶性人白细胞抗原G(s HLA-G)、抗子宫内膜抗体(Em Ab)水平的影响。方法:选取2017年8月至2020年10月河北省人民医院收治的ACA阳性复发性流产患者102例
按照分层抽样法分为对照组和滋肾育胎丸组
每组51例。对照组患者采用常规治疗
滋肾育胎丸组患者采用滋肾育胎丸治疗。采用酶联免疫吸附试验法检测两组患者肿瘤坏死因子相关蛋白12(CTRP12)、s HLA-G、抗缪勒管激素(AMH)、前列腺素E2(PGE2)、环氧化酶2(COX-2)、β人绒毛膜促性腺激素(β-HCG)水平和抗精子抗体(As Ab)、Em Ab及ACA表达水平
采用全自动生化分析仪测定孕酮(P)、黄体生成激素(LH)及睾酮(T)水平
观察两组患者的临床疗效。结果:与对照组相比
滋肾育胎丸组患者治疗后的CTRP12、s HLA-G水平明显升高
AMH水平明显降低
差异均有统计学意义(P <0.05)。与对照组相比
滋肾育胎丸组患者治疗后的P水平明显升高
T、LH水平明显降低
差异均有统计学意义(P <0.05)。与对照组相比
滋肾育胎丸组患者治疗后的PGE2、COX-2及β-HCG水平明显升高
差异均有统计学意义(P <0.05)。与对照组相比
滋肾育胎丸组患者治疗后的Em Ab、ACA及As Ab阳性率明显降低
差异均有统计学意义(P <0.05)。滋肾育胎丸组患者的治疗总有效率为94.12%(48/51)
与对照组的78.43%(40/51)相比
差异有统计学意义(P <0.05)。结论:滋肾育胎丸治疗ACA阳性复发性流产患者
可有效提高患者s HLAG水平
降低Em Ab阳性率
改善患者性激素水平
效果显著。
OBJECTIVE: To explore the effect of Zishen Yutai pills on the level of soluble human leukocyte antigen G( s HLA-G) and anti-endometrial antibody( Em Ab) in patients with recurrent abortion with positive anticardiolipin antibody( ACA). METHODS: Totally 102 patients with recurrent abortion with positive ACA admitted into Hebei General Hospital from Aug. 2017 to Oct. 2020 were extracted to be divided into the control group and Zishen Yutai pills group via the stratified sampling method
with 51 cases in each group. The control group was treated with conventional treatment
while the Zishen Yutai pills group received Zishen Yutai pills. Enzyme-Linked immunosorbent assay( ELISA)was used to detect tumor necrosis factor-related protein 12( CTRP12)
s HLA-G
anti-Mullerian hormone( AMH)
prostaglandin E2( PGE2)
cyclooxygenase 2( COX-2)
β-human chorionic gonadotropin( β-HCG)
anti-sperm antibody( As Ab)
Emab and ACA. The levels of progesterone( P)
luteinizing hormone( LH) and testosterone( T)were measured by automatic biochemical analyzer
and the clinical efficacy of two groups was observed. RESULTS:Compared with the control group
the levels of CTRP12 and s HLA-G in the Zishen Yutai pills group increased significantly
and the levels of AMH decreased significantly after treatment
and the differences were statistically significant( P < 0. 05). Compared with the control group
the level of P increased significantly
and the levels of T and LH decreased significantly in the Zishen Yutai pills group after treatment
with statistically significant difference( P <0. 05). Compared with the control group
the levels of PGE2
COX-2 and β-HCG in the Zishen Yutai pills group increased significantly after treatment
with statistically significant difference( P < 0. 05). Compared with the control group
the positive rates of Em Ab
ACA and As Ab in the Zishen Yutai pills group decreased significantly after treatment
and the difference was statistically significant( P < 0. 05). The total effective rate of Zishen Yutai pills group was 94. 12%( 48/51)
compared with 78. 43%( 40/51) of the control group
the difference was statistically significant( P <0. 05). CONCLUSIONS: Zishen Yutai pills in the treatment of positive ACA can increase the level of s HLA-G
decrease the positive rate of Em Ab and improve the sex hormone of patients with significant efficacy.
滋肾育胎丸抗心磷脂抗体阳性复发性流产可溶性人白细胞抗原G抗子宫内膜抗体
Zishen Yutai pillsRecurrent abortion with positive anticardiolipin antibodySoluble human leukocyte antigen GAnti endometrial antibody
0
浏览量
22
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621